Artemisinin Cancer Protocol Success Stories

Here we describe an anti-cancer protocol using the natural herb artemisinin (from sweet wormwood) plus supplemental iron, vitamins C, D and a restricted diet and increased exercise on patients with cancer, developed by Doctors and Professors from Washington University from their research studies, (research review by Chris Woollams; references at end of article).

Artemisinin bound to ferritin iron

Artemisinin is a natural compound that reacts with iron to form free radicals which can kill cells. Cancer cells require and uptake a large amount of iron to proliferate. They are more susceptible to the cytotoxic effect of artemisinin than normal cells. These statements came from a study in 2005. (1).

In 2008, the same researchers at the University of Washington in Seattle produced a unique compound involving the Traditional Chinese Medicine, artemisinin, from Artemisia annua or Sweet Wormwood, bound to ferritin. We covered the research HERE.  At the time, Henry Lai of the Department of Bioengineering said “By itself, artemisinin is about 100 times more selective in killing cancer cells as opposed to normal cells. But the tagged compound was 34,000 times more potent.”

Cancer cells express a large concentration of cell surface transferrin receptors that facilitate uptake of the plasma iron-carrying protein transferrin via endocytosis. Thus cancer cells contain far more than healthy cells contain - and use it to maintain their high rates of cell division. When they need some they make a special protein ‘signal’ on their surfaces, and the body’s metabolic systems deliver the iron to the signal, wrapped in the protein package because free-floating iron in the blood stream would be quite toxic. The cancer cells then take in the whole iron ‘package’.

Artemisinin itself attacks the energy production systems of pathogens – about a third of all parasites, yeasts, and most ‘bad’ bacteria such as E. coli. Artemisinin also attacks cancer cells. It kills about 100 cancer cells for every healthy cell in laboratory experiments – that’s about 10 times more effective than the average chemotherapy drug. In science, artemisinin has an endoperoxide capacity, that interacts with heme, especially in situations that increase iron in cancer cells.

Thansferrin is a glycoprotein that your body makes to transport the iron through the plasma. Once it arrives at its destination  ferritin stores iron in the cell (2).

While it’s pretty harmless in the absence of iron, artemisinin is highly toxic in the presence of ferritin and makes large volumes of free-radicals. This is not my view but that of Dr. Narendra Singh and Professor Henry Lai, Department of Bioengineering, and Professor of Chemistry Tomikazu Sasaki, all of the University of Washington.

So these researchers added a little ‘tag’ to the artemisinin, so it stuck to the signal protein on the cancer cells’ surface. When the iron package arrived at the signal, the cancer cells took everything inside – iron/protein package plus the artemisinin. Inside the cancer cell, free radicals were produced in abundance and the cancer cell died. About 30,000 cancer cells were now killed for every one healthy cell in the studies.

The researchers went on to use their creation with breast cancer (where it killed 98% of cancer cells within 16 hours compared to artemisinin alone at 28%), leukemia and brain tumours and it was licensed by the University of Washington to a company, Artemesia Biomedical, set up by Lai, Sasaki and Singh.

Go to: Artemisinin and brain tumours

While orthodox Medical journals like to dismiss the anti-cancer benefits of artemisinin with the usual ‘Lack of convincing evidence’ mantra, a number of high level scientists can’t agree with that view. In 2018 there was a full review of artemisinin and its effects on cancer (3) by Yunqin Zhang and others, in China.

CANCERactive also has a review on artemisinin –

Go to: Artemisinin and cancer, yeasts and parasites

In fact, it is a powerful herb and we warn on its side-effects HERE.

The Artemisinin anti-cancer protocol

Following human experiments, the Singh team developed a Protocol (4) using a reduced carbohydrate diet with vitamin D supplementation (5,000IUs) and encouraged exercise. Note - artemisinin can cross the blood brain barrier.

• Singh believes that plant iron from a plant-based diet provides ferric iron. By providing 1 gm of vitamin C (with a little oil) after meals, the ferric iron converted to ferrous iron in the cancer cell and thus the vitamin C encourages greater uptake.
• The Artemisinin should be given on an empty stomach but with a little yoghurt (which contains no iron) to help absorption, and before bed as the immune system falls at night and cancer cells proliferate more.
• Dose is 100 mg of artemisinin supplement per 10 kg of body weight.
• Some practitioners believe it should be taken with 1000 mg of cod liver oil, and 3 gm of Conjugated Linoleic Acid.
• It is sometimes observed that the body becomes ‘used to’ artemisinin and the herb under-performs. For this reason some practitioners ‘pulse’ the herb – 5 days on, 3 off; or 8 days on, 3 off.

Please Note:

The protocol should not be used by smokers, people having radiotherapy, or people taking glutathione. None of these should have been used in the previous 6 months. Caution is urged by CANCERactive, if a patient has impaired liver function.

Plasma levels are higher in women than men, and peak after 90 minutes.

Singh uses the treatment for up to a year. The artemisinin needs to be of the highest purity and so a good supplier is recommended.

Fenbendazole & Artemisinin for Cancer

While fenbendazole and artemisinin show promise as supplemental cancer therapies, it’s imperative to have open and honest conversations with your oncologist before incorporating alternative methods into a treatment plan. Though initial research is encouraging, large-scale clinical trials demonstrating safety and efficacy in humans are still lacking for both compounds. Furthermore, neither fenbendazole nor artemisinin have FDA approval for cancer treatment at this time.

As with any medical therapy, risks and benefits must be weighed carefully on an individual basis under a physician's supervision. With an integrative approach that combines conventional and complementary modalities, we hope to expand and improve therapeutic options against cancer. Through further research, we will gain greater clarity on which supplemental regimens may benefit which patients, allowing for personalized, integrative care for those battling cancer. An open-minded approach gives us the best chance to overcome this devastating disease.

*****

References

1. Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds; Henry Lai, Tomikazu Sasaki, Narendra P Singh; rt Opin Ther Targets. 2005 Oct;9(5):995-1007.  
2. Transferrin vs Ferritin, Wikipedia - https://en.wikipedia.org/wiki/Transferrin
3. Antitumour Research on Artemisinin and its Bioactive Derivatives; Yunqin Zhang et al; Nat Prod Bioprospect. 2018 Aug; 8(4): 303–319
4. Protocol - https://www.facebook.com/notes/curt-michael-artemisinin-cancer-and-health-protocols/artemisinin-cancer-protocol/1418737001604274/

Source: https://www.canceractive.com/article/artemisinin-anticancer%20protocol